Click image to view original image
Synonyms: 4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile;Femara
CAS: 112809-51-5
MF: C17H11N5
MW: 285.3
Product Categories: Anti-Cancer;Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Letrozole;Antineoplastic;All Inhibitors;anti-neoplastic;Inhibitors;Intermediates & Fine Chemicals;Antibiotics;Aromatics;Heterocycles
Chemical Properties: white to light yellow crystal
Usage: A nonsteroidal aromatase inhibitor structurally related to Fadrozole. Antineoplastic .
Packing:1kg/foil bag or as required
Letrozole (Femara) Application:
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreadingLetrozole (Femara) Application:
